Ms Padron Vega had also been found to have failed in her duties as an OV by being unprepared for, and unaware of, new regulations. She also did not take adequate steps to ensure that the two individuals for whom she had given veterinary certification were licensed to perform slaughter in accordance with the regulations.
Ms Padron Vega originally applied for restoration in December last year, at which time the Disciplinary Committee had concerns about her keeping up-to-date with the knowledge and skills needed to return to practice, and decided to adjourn for six months to allow her to prove that it was appropriate to restore her name to the Register.
At the latest hearing, Ms Padron Vega sought to address the concerns that the Committee had raised about her professional development. In addition to the documentation she provided in her original restoration hearing, which included positive testimonials from colleagues, she provided evidence of her continuing professional development (CPD).
This included a letter from her previous employer, who confirmed she had more recently worked for them as a Certification Support Officer from February to March 2021, where they received positive feedback on her conduct.
The documentation also included a letter from another practice confirming that Ms Padron Vega had been offered a position of employment with them, and a separate letter from practice veterinary surgeon, Dr Khan MRCVS, confirming that he would be her mentor. Dr Khan also confirmed that she had been coming to the practice for work experience and he considered her to have good working knowledge of current medicines used within the practice. He further outlined in his letter what CPD support the practice would be providing for Ms Padron Vega as part of her employment with them.
An additional piece of evidence was a testimonial from Dr Max Rutana MRCVS who confirmed that Ms Padron Vega had worked unsupervised for a period of three weeks, and that he found her clinical notes during this period to be satisfactory and they received no complaints about her conduct from clients.
Ms Padron Vega also submitted CPD documentation which confirmed she has taken a Certification Support Officers’ course and examination in mid-December 2020.
In response to questions from the Committee about her small animal practice experience and how long she had been shadowing Dr Khan for, Ms Padron Vega explained that she had completed 80 hours of shadowing with Dr Khan and that in her future employment under his mentorship, he would be available to support her. She also explained that her job offer was evidence that she would continue to be trained in the relevant area of veterinary work.
Cerys Jones, chairing the Disciplinary Committee and speaking on its behalf, said: “During the hearing, we heard evidence from Dr Khan who provided reassurance of Ms Padron Vega’s continued professional development with his practice and the ongoing supervision that she would be under. He explained that the supervision would last at least three months.
“The Committee’s view is that Ms Padron Vega accepts the findings of dishonesty that were made against her at the original Inquiry hearing. In her Reflective Statement, she acknowledges that veterinarians have a professional responsibility to ensure the integrity of veterinary certification, that she is now aware that when signing documents as a veterinary surgeon they need to be approached with care and accuracy. Further she has undertaken a CPD course on this very ethical issue and has passed the examination set at the end of that course. The Committee is confident that Ms Padron Vega is unlikely to repeat the conduct which resulted in her being removed from the Register. It is the Committee’s decision that she should be restored to the Register.”
Designed with the RCVS Standards and Advice team, the ‘Client confidentiality’ course explains the steps veterinary teams need to take when deciding whether or not to make a disclosure, and how to remain compliant with their professional obligations under the Code of Professional Conduct.
Senior Standards and Advice Officer, Victoria Price said: “Deciding to breach confidentiality is often a difficult decision with no right or wrong answer.
"The course should help learners to feel confident about what to consider in order to make justified and well-supported decisions.”
The course takes around one hour to complete.
academy.rcvs.org.uk
The invaluable work done by equestrian vets in the UK is to be recognised with a new award sponsored by leading equine insurance provider Petplan Equine at the Animal Health Trust Awards in November. The ‘Petplan Equine Vet of the Year' award people's vote will reflect the huge contribution made by vets to the equine community.
Owners and riders will be able to nominate their equine vet for the award if they feel that they are deserving of the recognition that this accolade would bring. Veterinary practice personnel are also encouraged to nominate a colleague who they feel has gone beyond the call of duty. Leaflets have been sent to practices across the UK outlining how to nominate and people can also register through the Petplan Equine website www.petplanequine.co.uk. A short list will be drawn up from the nominations received and an independent panel will decide the winner, who will receive his or her award at the Animal Health Trust Equestrian Awards in London on November 6th 2008.
This year marks the 20th anniversary of the Animal Health Trust Equestrian Awards, which recognise the outstanding achievements made by horses, riders, owners and trainers throughout the equestrian world. This milestone coincides with Petplan Equine's 20th anniversary and, since 1994 when the Petplan Equine Charitable Trust was founded, it has raised over £5 million, almost £500,000 of which has been donated to the AHT to fund research and development.
Jo Whitaker of Petplan Equine says: "It has been a privilege to be involved with the AHT Awards over the years and we look forward to this exciting 20th anniversary year. Petplan Equine has sponsored the Eventing Award for the past three years but this new award will recognise the commitment and hard work of people within the equine veterinary profession and the service they provide to horse owners. Horse welfare is paramount at Petplan Equine and we are committed to promoting responsible horse ownership, through our wide range of policies, our charitable contributions and our Horse Handbook. This award will give the equine community the opportunity to acknowledge and celebrate the vet who has made the most outstanding contribution to the care of horses."
To nominate go to www.petplanequine.co.uk. The closing date for nomination is 3rd October 2008.
Developed in conjunction with Fiona Lovatt BVSc PhD FHEA DSHP DipECSRHM FRCVS, past president of the Sheep Veterinary Society and RCVS-recognised specialist in sheep health and production, NoBACZ Navel disinfects and dries the navel in a couple of hours and seals with a colourful, natural resin that forms a long-lasting waterproof barrier to protect against bacterial ingress from the environment.
It can also be used on the area around ear tags in lambs and calves.
Nobacz Navel can be applied by dipping or spraying and contains a bitter agent to deter ewe or cow interference.
Fiona said: “Attention to detail is an essential component in the care of neonatal lambs.
"To reduce the risks of joint ill, shepherds need to do whatever they can to protect lambs from bacteria infecting either the navel or the ears at the point of tagging.
"This product has been carefully designed to both desiccate the area and to form a barrier to protect these vulnerable sites.
"I’ve seen it used successfully in a number of flocks now – both in late lambers from last year and early lambers from this.”
https://nobacz.com
Helen Ghosh, Defra's Permanent Secretary today confirmed the appointment of Nigel Gibbens as Chief Veterinary Officer (CVO). Nigel qualified as a veterinary surgeon in 1981 and has spent most of his career involved in animal health and welfare with lead roles on international trade and exotic diseases. Since 1990 he has held a variety of operational and advisory positions in the Government's veterinary and policy services. Nigel moved to the central animal health policy group in 1996 and worked on international trade for eight years, followed by surveillance and control of Bovine Spongiform Encephalopathy and animal welfare. He has also worked in general veterinary practice and for Government veterinary services in Belize and Yemen. He said: "I am delighted to have been appointed to this important and challenging role. I intend to build on the successes and lessons learned from recent exotic disease outbreaks to ensure that these risks continue to be managed as effectively as possible. "Defra and its Agencies must continue to work with animal keepers and the veterinary profession to deal with existing challenges such as Bluetongue and Tuberculosis, and to maintain good animal welfare standards and surveillance to identify and deal with any new threats. The Government will increasingly develop policy on disease control in partnership with key stakeholders and I am committed to ensuring that those decisions are founded on the best possible veterinary advice." Nigel's first event as CVO will be to represent the UK at the World Animal Health Organisation General Session in Paris from 25 to 30 May.
To meet market demands and ensure that their customers comply with regulatory requirements, British manufacturer Labcold has released the first models in a new range of vaccine and pharmaceutical refrigerators designed specifically for this use from the ground-up. The company says more models will be added to the range over the next 12 months.
When storing temperature-sensitive vaccines and pharmaceuticals, Veterinary Practices need to ensure compliance with an ever-increasing burden of legislation, regulations and guidelines, such as the latest VMD Code of Practice, (Oct 2007). The BVA Good Practice Guide - Standard Operating Procedure 04 on the storage of medicinal products in permanent premises says as follows:
Refrigerated storage must:
Although this guidance stops short of specifically excluding the use of domestic refrigerators, Labcold says professional products are more appropriate since they are built specifically for vaccine and pharmaceutical storage. Labcold refrigerators all fully compliant and have locking doors plus a host of handy options including capacity, glass doors and a new divided-drawer system.
Robin Gregson, Sales & Marketing Director at Labcold said, "Our whole product range is constantly being updated to ensure that we provide our customers with market-leading solutions. Many previous pharmacy refrigerators have simply been modified designs of domestic fridges, whilst our new range, the result of three years work, is one of the few on the market to be designed specifically for pharmacy use from the ground up."
For full information on all Labcold products, including portable refrigerators suitable for farm vets please visit http://www.labcold.com/ or contact sales@labcold.com / Telephone 0870 3001001 for a free copy of the latest Product Guide.
RCVS President Jerry Davies has apologised to the profession for its overspend on IT and development works at Belgravia House.
In fact, the apology was made to a meeting of BVA Council back on 7th December. VetSurgeon.org understands the College thought the apology would be widely promulgated shortly thereafter, and only later realised that this hadn't happened.
As a result, the College has now decided to publish Dr Davies' presentation in full.
At the meeting, Dr Davies set out more background about the two RCVS projects under review, explained the decisions taken at the time and the finances involved.
He also described how Professor McKelvey's recommendations were being actioned, alongside those of the College's Governance Review Group which were already underway.
Dr Davies reiterated that the College had always intended to publish the report in full, but that external legal Counsel had advised that to do so would be unlawful under the Data Protection Act.
According to the College, it was not possible to redact the report to an acceptable extent, as the personal data in question were referred to throughout a large proportion of it.
However, Dr Davies did apologise to the profession, saying: "In closing, I would like to emphasise that I, as President of the RCVS, am sorry for what has happened, but I hope you will appreciate that steps are being taken, in particular the setting up of the Audit and Risk Committee, to strengthen governance within our College."
Axiom Veterinary Laboratories is launching MiLab, a new range of in-practice analysers at the BSAVA Congress.
Axiom says the range will be supported with a comprehensive range of additional services, from installation and training through to technical support and maintenance.
Martyn Carpenter, Managing Director of Axiom Veterinary Laboratories said: "An increasing number of UK veterinary practices are opting to carry out a higher proportion of laboratory testing in-house but, in order to do this successfully, they need equipment which is reliable, cost-effective and easy-to-use. Two products in the MiLab range will be showcased at BSAVA, both of which have been selected following extensive validation and correlation testing in Axiom's veterinary laboratories."
The two new products are:
Martyn said: "Investing in significant new equipment is always challenging for practices and we have spoken to many over the last 18 months to understand their experience of and current requirements for in-house analysis and, in particular, the level of support they receive. Practices working with us can be confident that we are offering the very latest in analyser technology, which has been tested rigorously for reliability, economy and ease of use. They can also feel secure in the knowledge that we provide a high level of service and support, delivered by our own highly skilled laboratory technicians."
For more information, contact Steve Clarke at Axiom on 01626 357756.
Recent graduate, Sophie Gumble, from Head & Head Vets in Helston, Cornwall, has won a week for two in a luxury cottage in Cornwall.
Sophie won the prize after entering a draw run by Vetlife at the Veterinary Defence Society recent graduate meetings and the SPVS Lancaster Final Year Students’ Seminar last year.
The competition is run annually to raise awareness amongst younger members of the profession about the support that Vetlife provides through its support services: Vetlife Health Support, Vetlife Helpline and Vetlife Financial Support.
The prize, which was generously donated by former Vetlife Director Nicky Paull, will be offered again at the VDS reunions in 2016.
Sophie said: "I am a 2014 Liverpool graduate from Herefordshire, who entered the competition at the VDS reunion. The weekend was very useful and a great opportunity to catch up with friends and revive crazy dance moves!
"It has been a big move down to Cornwall. The busy life of a new vet, coupled with many weekends racing up the M5 to help with the family farm, has meant I am yet to really get the chance to enjoy and explore what the county of pasties and Poldark has to offer! I am excited to now have the chance to explore new parts of this wonderful county!"
The WSAVA is calling on veterinary surgeons around the world and anyone with an interest in veterinary – and human – medicine to sign the petition to ensure access to ketamine in the face of lobbying by some countries, principally China, to have it put under international scheduling.
According to the WSAVA, proposals for international control stem from the misconception that ketamine is merely a 'recreational drug.' The WSAVA says this is inaccurate and devalues its huge contribution to human and animal medicine.
Dr Walt Ingwersen, WSAVA President Elect and Member of the WSAVA’s Global Pain Council, said: "In 2015, the WHO Expert Committee on Drug Dependence (ECDD) stated that the abuse of ketamine does not cause a global public health threat and that control would limit access for those using it as an anaesthetic. This view was confirmed at a meeting of the UN Commission on Narcotic Drugs in March 2016, helped by strong support view from the global medical and veterinary communities. However, China has repeated its view that ketamine should fall under international scheduling and we have no doubt that it will raise the issue again. This mean the risk to ketamine remains."
He added: "Ketamine is a safe anaesthetic which can be used without oxygen, ventilators, electricity and the support systems required for other products, making it the only anaesthetic suitable for both medical and veterinary use in lower and middle income countries. If developing countries were denied access to it, which would be the effect of international scheduling, the effects on veterinary medicine, human health and animal welfare would be devastating."
Dr Ganga de Silva, President of the Society of Companion Animal Practitioners of Sri Lanka, said: "Sri Lanka is a poor country with an underdeveloped veterinary profession. If ketamine was not available, in my opinion, all surgeries would have to cease as almost all of the veterinarians in the country rely on it for anaesthesia. The result would be suffering for animals and it would also seriously impact our ability to control rabies as we would not be able to carry out spay and neuter programs on stray dogs."
Dr Nancy Shaffran CVT, VTS(ECC), President of the International Veterinary Academy of Pain Management, said: “In addition to its use as an anaesthetic agent, ketamine is a critical medication used in the pain management in animals. The mechanism of action of ketamine (NMDA receptor antagonism) delivered as a Constant Rate Infusion has been well established to be effective in the prevention and correction of severe neuropathic pain and spinal cord wind-up. The loss of ketamine in veterinary practice would result in the needless suffering of many patients and we strongly oppose this action. We are very grateful for WSAVA’s efforts to keep ketamine available for our patients."
Dr Walt Ingwersen added: "Ketamine is also used in human medicine as it has a particular value for use 'in the field' - for instance, in treating trauma patients, those with traffic and sporting injuries or affected by natural disasters and conflict. Taking these factors together, it is clear that ketamine is an essential medicine and we are determined to ensure that it remains freely available. We are continuing to harness our global veterinary community to highlight the importance of ketamine because this is a battle our patients can’t afford us to lose. We ask all those agreeing with to sign our petition and help our collective voice grow."
The petition is here: http://chn.ge/1RFSou6.
The WSAVA’s Global Pain Council has produced a range of tools and resources, including an infographic, to support its ketamine campaign. They can be accessed here: http://www.wsava.org/educational/global-pain-council
CVS says the use of ear cytology in OE is beneficial, both as a diagnostic and to evaluate the response to therapy.
However, in 2019 the company looked at 26,269 of its patients and found that ear cytology was only being used in 19.2% of cases, in line with the rest of the profession.
Only 11% of cases were being provided with in-house point-of-care cytology, whilst 8.2% had it performed externally.
80.8% of patients with OE were being prescribed antibiotics without cytological support, with 5% of these the highest priority critically important antibiotics (HPCIAs).
This low level of cytology use in primary care was suspected to be a major contributory factor to the significant use of unnecessary antibiotics.
To support its practices, CVS first looked at the barriers to performing ear cytology interventions, which were identified as a lack of confidence in using the microscope (particularly focusing on x100 and identification of pathological events), a perceived lack of time, insufficient or poorly working equipment, a lack of access to equipment, and the perception that cytology does not change the treatment choice or outcome.
As a second step, a minimal list of cytology equipment was developed to ensure that all sites had the right kit.
New equipment was then supplied to a practice if it did not meet minimum standards.
The company then produced education and resource materials, including new guidelines, imagery and video guides, to upskill both its vets and nurses.
The training focused on: equipment maintenance, cleaning and troubleshooting, how to use the microscope – including x100 magnification and the slide oil immersion technique, how to identify pathological changes, and time management to get a consultation done – including swabbing, microscope analysis, diagnosis and client consultation.
Each site was then provided with its own data, so that it could monitor progress.
Elizabeth McLennan Green, CVS Clinical Director for the North, said: “One of our goals with this project was to minimise the number of antibiotics prescribed without associated diagnostics, and to use ear cytology to guide therapy and response to treatment for the benefit of our patients and clients.”
“We know that low ear cytology interventions are an issue across the profession. We wanted to do better. So ear cytology has been our first and longest running clinical improvement project.
"We’re thrilled with the brilliant results our colleagues are now achieving.”
There's a video presentation about the project here: https://vimeo.com/875515008/bdc3ee5920
Photo: Emily Spencer, Head Vet at Castle Vets
RCVS Council recommended the increase due to inflationary pressures and increased business costs.
Dr Tshidi Gardiner MRCVS, RCVS Treasurer, said: “We recognise that these are difficult economic times, so Council has endeavoured to limit the fee increase as far as possible; however, in proposing these new fees, Council has had to take account both of increased costs due to inflation, and of additional costs related to ensuring we are fulfilling our regulatory remit to the best of our abilities and meeting our strategic priorities.
“For example, increased costs related to the additional number of veterinary degrees coming on stream, modernising our membership database, our Charter Case Committee, the trial of our private prosecutions protocol against non-vets breaching the Veterinary Surgeons Act, and much more besides.”
Vets need to pay their annual renewal this year by 1st April.
Anyone who hasn't paid by 1st May will face a late payment charge of £35.
Anyone who hasn't paid by 1st June risks removal from the Register.
As part of the annual renewal process, vets also need to confirm their registration and contact details, declare any convictions and declare they are compliant with the College’s requirements for continuing professional development (CPD).
Anyone who expects to encounter any difficulties in paying their fees is asked to contact the RCVS Finance Team on finance@rcvs.org.uk or 020 7202 0722.
Tip 1 – Make sure that pet owners understand the functions of a microchip properlyMichelle says: "Some customers I’ve spoken to wrongly believe that microchips function as GPS trackers. To help manage pet owners’ expectations I always stress the importance of a microchip in lost pet recovery scenarios, where they serve as a permanent form of identification."
Tip 2 – Stress the importance of pet owners updating their contact details with their microchip providerMichelle says: "Pet owners often think that updating contact details with their vet will automatically sync these changes with the microchip database. It’s vital to inform owners that they must separately update their contact information with their microchip database. I’d recommend regularly reminding pet owners to check and update their microchip registration."
Tip 3 – Reassure pet owners that microchips are safe for their catsMichelle says: "I’ve had some owners express worries about allergic reactions or rejection of the microchip by their cat's body. So it’s worth taking the opportunity to dispel this myth during routine wellness exams by explaining microchips are made from inert, biocompatible materials designed to be nonallergenic and nontoxic.
Tip 4 – Make sure to discuss the longevity of microchips with pet ownersMichelle says: Microchips are designed to last the lifetime of the pet without needing a power source and that their functionality can easily be verified during any veterinary visit. If you find an owner expresses concerns about this, you could offer to check the microchip as part of regular health checks to demonstrate its reliability.
Tip 5 – Emphasise how every cat needs a microchip – regardless of age or activity levelMichelle says: "All vets will know even indoor or elderly cats can escape or wander off and older cats can become disoriented more easily. It is worth reminding owners that microchipping is a safeguard, ensuring their pet can be identified and returned home if lost. The new law means that pet owners can also face a large £500 fine if their cat isn’t microchipped."
Tip 6 – Explain how not all microchips are the same and the importance of getting the right oneMichelle says: I often explain that microchips vary in terms of the technology they employ, such as the new 'Thermochip' by HomeAgain that also measures a cat’s subcutaneous temperature. It’s worth talking pet owners through the different microchips available and the database options so they can make an informed choice.
http://homeagain.co.uk/Cats
Intervet/Schering-Plough Animal Health has produced a new medicine record book to help producers effectively document animal health product usage, to coincide with the cattle pneumonia season.
The Resflor-sponsored booklet incorporates space to record all the necessary information to comply with legislative requirements.
Intervet/Schering-Plough livestock veterinary adviser Paul Williams MRCVS said: "If you are in the business of rearing, producing or treating farm animals that will end up as food for human consumption, you must keep a record of any veterinary medicinal product you give or treat them with.
"You must also keep proof of purchase of all veterinary medicinal products and keep all your records for a period of five years. A format for keeping all these records is set out in this book."
To order Resflor medicine record books to give your clients, ring: 01694 731777
An animal heath company is conducting a survey into veterinary surgeons' thoughts on digestive health conditions, including diarrhoea.
Everyone who participates in the survey will be entered into a prize draw to win £100 worth of John Lewis vouchers.
To take part, visit https://www.surveymonkey.com/s/digestive-health-survey.
The survey will remain live till 28th March 2014, and the results will be shared with participants in due course.
Lucy Chadwick, Head of Technical Services & Marketing at Forte Healthcare Ltd said: “Neonatal calf diarrhoea is a leading cause of death in the calf crop in the UK and Ireland.
"We are delighted to therefore offer this webinar discussing up to date information on what we can do to boost neonatal defences in the face of an NCD outbreak.
"Tune in to learn more about the importance of colostral antibodies and how the resecretion of antibodies plays a key role in gut protection.
"We will also discuss what factors can influence the effectiveness of a NCD vaccination programme and what this means for your farmers.”
You'll be able to ask questions during the event and the webinar will also be made available to watch on demand afterwards.
https://www.thewebinarvet.com/pages/forte-healthcare-register
The nominations allow practices to recognise someone at their workplace who has helped to hold up morale during a time when practices are facing unprecedented staffing and financial issues, and have taken it upon themselves to foster a positive work environment.
The Practice Wellbeing Star nominations were originally launched to accompany the Practice Wellbeing Awards, which have been cancelled this year because of the pandemic.
Liz Barton, SPVS representative on the Mind Matters Taskforce (pictured right), said: “With great regret we have had to postpone the Practice Wellbeing Awards as we recognise that practices may neither have the time nor resources right now to go through our comprehensive application process. However, there is still definitely a place for recognising those individuals who are going above-and-beyond to help their colleagues navigate their way through these difficult times.
"Nominating a team member is a great opportunity to discuss with your team and reflect on the positive things that are happening, and to nominate one person who has been particularly invested in contributing to creating positive team culture.
"The Practice Wellbeing Star nominations are open to all veterinary practices, and teams, including those working in universities, industry and business.
“We look forward to receiving your nominations and celebrating exceptional individuals who are committed to improving the mental health and wellbeing of their colleagues.”
Members of the veterinary team who are nominated for as a Practice Wellbeing Star will receive a certificate in recognition of their colleagues’ appreciation of their achievements.
Recipients of the certificate will also be entered into the prize draw for a pair of tickets to attend the joint SPVS and Veterinary Management Group Congress in January 2021.
Further information on how to nominate is on the Vet Wellbeing Award website at: vetwellbeingawards.org.uk/practice-wellbeing-star/
The closing date for Practice Wellbeing Star nominations is Friday 20 November 2020.
Intervet / Schering-Plough Animal Health has announced that Optimmune - which is used to treat Keratoconjunctivitis sicca (KCS) in dogs - is back in stock three weeks ahead of schedule following a temporary shortage in January.
Melanie Dass, product manager at Intervet / Schering-Plough Animal Health said: "We were aware that the shortage would happen so took steps to manage the supplies that were available and to resume production as soon as possible.
"We wrote to all our veterinary customers informing them of the likely shortage and fortunately, as a result of doing everything we could to minimise disruption, the product is now back three weeks earlier than expected and we are confident in our long term supply."
Melanie added: "We will be allocating stock in February to ensure all practices receive enough product to meet the needs of clinical cases, which amounts to approximately 125% of average monthly usage. This should allow a smooth return to normal deliveries in March.
"We would like to thank all our veterinary customers for helping us manage the allocation of the product and for their understanding during this difficult situation."
Any practices that require additional stock for clinical cases during February, should contact their Intervet / Schering-Plough account manager or the Veterinary Support Group on 01908 685685.
MSD Animal Health has launched FlockCheck 2012, its complimentary sheep diagnostic service that identifies whether enzootic abortion or toxoplasmosis is present in a client's flock.
FlockCheck 2012 requires vets to take blood samples from 6-8 aborting ewes. MSD says that at a time when many farmers are asking for veterinary diagnostic support to confirm or rule out potential Schmallenberg virus infection, it makes sense to investigate whether other diseases are present in the flock at the same time.
MSD Animal Health ruminant veterinary adviser Drew McGurren MRCVS said: "Based on the previous two years' FlockCheck data (2011 and 2010), on average over 86% of submitted samples tested positive for toxoplasmosis and more than 62% were positive for enzootic abortion. Around 43% of samples showed exposure to both diseases.
"With lamb prices still remaining buoyant it has never been more important to ensure farmers minimise lamb losses. The 2012 FlockCheck service allows vets to identify whether toxoplasmosis or enzootic abortion is the cause of any aborted lamb losses and provides a starting point for discussions around the value of vaccination programmes with Enzovax and Toxovax."
Vets are asked to submit unit blood samples with the new 2012 FlockCheck forms.
Genitrix has launched a scheme to help vet practices generate revenue through increasing sales of its canine mobility product, C2Collaplex. The scheme offers a money-back guarantee if clients and practices don’t see clear benefits from using C2Collaplex on dogs with mobility problems within a month.
In order to validate the scheme, clients are asked to complete a simple mobility score sheet and return it to the practice one month from the date of their original consultation. If both vet and client agree that C2Collaplex has made no difference, the practice will refund the client and Genitrix will forward on a replacement pack of C2Collaplex.
C2Collaplex, designed to promote the continuation of normal joint function in ageing and less mobile dogs, contains a range of nutritional substances, including Glucosamine HCl, Chronodroitin Sulphate, Vitamin C and Manganese, which help to support the musculo-skeletal system.
In addition, it contains purified Type II collagen which is the major protein of the cartilage in the joints. C2Collaplex is the only veterinary product to provide this protein in a purified form. According to Genitrix, it works by helping to switch off adverse processes and keeps cartilage normal.
In a retrospective study of 100 dogs presenting to practice with mobility problems, C2Collaplex was given as the only supportive agent and over 80% of veterinary surgeons and owners perceived a benefit from its use.
Commenting on the launch of ‘C2Collaplex Money Back Guarantee Scheme,’ Rob Watkins, Marketing Director of Genitrix, said: “The C2Collaplex Money Back Guarantee Scheme offers a win/win. It gives pet owners a well-priced, next generation product, which will help their dog. For the practice, it helps to build a strong revenue stream, with the guarantee of a refund if it fails to help an individual patient.”
For further information on participating, practices should contact Genitrix on 01403 786345.
The National Office of Animal Health (NOAH) has launched a new 'Use Medicines Responsibly' campaign.
The main thrust of the campaign is an initiative by NOAH to encourage pharmaceutical companies to add: 'Use Medicines Responsibly' as a strapline to their own advertising campaigns, with a link to the NOAH information resource for prescribers and users of animal medicines: www.noah.co.uk/responsible.
Speaking at the NOAH annual members' conference in Northampton, NOAH chief executive Phil Sketchley said: "NOAH believes responsible promotion of animal medicines to be an important link in the chain towards responsible use. Companies' promotional material can educate prescribers and users of animal medicines to the benefit of their animals' health and welfare.
"We believe this new advice resource, with the reminder on advertisements, will help."
National charity Canine Partners, which provide specially trained assistance dogs to people with disabilities, will benefit from an Eastbourne vet's efforts to run the Brighton Marathon on Sunday 10th April in less than 3.5 hours.
Simon DeVile is undertaking a gruelling training scheme, covering up to 50 miles a week, to ensure peak performance when he takes to the streets to raise money for Canine Partners - a charity close to his heart.Simon, 44, is one of the partners at St. Anne's Veterinary Group in Eastbourne. He started running to keep fit in 2006 and has since run the London Marathon twice and the Beachy Head Marathon three times. Simon regularly comes into contact with canine partner puppies because a local fundraiser and puppy parent is one of his clients. His own dog is also part of a locally bred litter, five of which went on to train as canine partners.Simon said: "I wanted to enjoy a new marathon experience this Spring and Brighton proved very popular last year. My aim is to enjoy the race but hopefully get below 3hrs 30 mins and raise money for Canine Partners. I am very aware what an important role these dogs play in the lives of a person with disabilities. I am also continually impressed with the way Canine Partners look after the dogs in their care so well."
If you would like to support Simon's efforts, visit: http://www.justgiving.com/Simon-DeVileCanine Partners still has charity places available for The Brighton Marathon. If you would like to take up the challenge, please contact Jill Green on 01730 716014.
Ceva Animal Health has launched Vectra 3D, a broad spectrum topical ectoparasiticide for dogs which is effective against fleas, ticks and flies.
Vectra 3D contains a formulation of a brand new active called dinotefuran, pyriproxyfen and permethrin.
According to the company, Vectra 3D provides a rapid flea kill within two hours for dogs on current treatment and complete protection against the major vectors: fleas, ticks, sand flies, mosquitoes and stable flies1. Additionally, because dinotefuran kills on contact, it is claimed to reduce the incidence of flea feeding1.
Vectra 3D is applied in a line from the base of the tail to the neck using a patented applicator with an elongated tip, designed to make it easy to apply the product through the hair directly onto the skin. The applicator is also designed to provide accurate dosing without making any mess, as nothing comes out until the tube is squeezed.
Ceva highlights that the number of people travelling with their pets has increased by 61% since 20122, and that Vectra 3D is the only topical ectoparasiticide that offers repellent action against sand flies for one month, together with protection against mosquitoes and stable flies.
Julia Wood, product manager at Ceva Animal Health said: "Vectra 3D is an innovative formulation which uses a unique, easy-to-administer applicator to provide complete protection against fleas, ticks and flies. And with spring nearly upon us, it's time to start talking to clients about flea treatments, such as Vectra 3D."
To support the launch of Vectra 3D, Ceva is hosting a series of CPD meetings at venues across the UK. Accounting for two hours CPD, the afternoon meetings will cover vector-borne diseases, the importance of ticks in the UK and product information on Vectra 3D. They will be presented by Ian Wright BVMS BSc MSc MRCVS and Richard Wall BSc MBA PhD FRES and take place at:
For further information, contact your Ceva Animal Health territory manager or email Ceva Animal Health on customerservicesuk@ceva.com.
The RCVS and the BVA have announced the launch of Vet Futures, a jointly funded initiative designed to stimulate discussion about the future of the profession, and help its members prepare for and shape it.
The initiative will draw on the experience and insight of a wide range of individuals and organisations, including veterinary surgeons and nurses, veterinary bodies, farmers, pet owners and other key stakeholders.
The objective is to understand where the provision of veterinary services is currently heading, whether this is in the best interests of the profession, animal owners and the public at large, and what might be done to shape an optimal future for the veterinary team, keeping animal health and welfare at its heart.
In the project's first phase, independent researchers will gather evidence via focus groups, phone interviews and desk-based research, in addition to the gauging of opinion through events, the internet and social media.
This evidence gathering will be followed by an engagement phase, where the profession will be asked for their feedback on initial thoughts; a period of analysis, where a report will be written by the independent researchers; and, finally, there will be an action phase, where key strategic issues will be identified, together with a clear plan for action from the BVA and the RCVS, as well as other organisations and individuals.
Professor Stuart Reid, RCVS President. said: "The RCVS is implementing a programme of reform to make it a first-rate regulator, but how do we also make ours a first-rate profession, that is resilient and agile enough to meet future demands?
"The Vet Futures project will not just be about horizon-scanning, but getting a fix on those issues over the horizon that we may not yet have considered, such as the use of emerging technologies.
"It's an exciting challenge and I am looking forward to members of the veterinary team getting involved so that, together, we can develop an action plan that will deliver a sustainable future for the profession."
John Blackwell, BVA President, said: "It is no secret that the veterinary profession is changing rapidly and that is why the theme for my presidential year is 'driving change and shaping the future'. It is essential that we come together to map out where we want to be as a strong and trusted profession and identify how we can make that happen.
"On such cross-cutting issues it is appropriate that the two leading professional bodies come together to provide joint leadership for the profession, but we are keen to engage as many individuals and stakeholders as possible. It is designed to be a hugely collaborative project and we want to hear voices from across the whole profession and the whole veterinary team."
The project has a dedicated website www.vetfutures.org.uk where the latest events, reports and publications will be found. There will also be a 'topic of the month' for the duration of the project, with controversial opinion-pieces being posted to stimulate debate from within the profession and amongst animal owners and other stakeholders.
Merial Animal Health has revealed the latest MOO test figures which suggest that the productivity of four out of five UK dairy herds is compromised by high levels of gutworm.
The company says it has been helping dairy farmers to assess the level of gutworm challenge in their herds since 2009 by supporting and promoting MOO tests. The test measures the level of antibody to gutworm (Ostertagia ostertagii) that is present in a bulk milk sample and can determine if the herd has been exposed to low, medium or high challenge.
Data from five years of MOO tests shows that whilst there was a steady reduction in the number of herds with a high challenge between 2009 and 2013, the figure rose in 2014. In 2009, 93% of herds tested high and by 2013 this had fallen to 71% but this rose again to 88% last year.
Merial says that whilst these figures show an overall reduction in challenge since 2009, levels of gutworm across the UK dairy herd are still very high. Those animals affected will suffer from the negative impact of a parasite burden on productivity and fertility.
Between 2009 and 2014 nearly 900 dairy herds across the UK have been tested. During that time several counties had significant numbers of herds with high gutworm challenge results. This included Cheshire (85%), Cornwall (93%), Cumbria (91%), Dyfed (92%), Lancashire (90%), North Yorkshire (83%), Shropshire (86%), Somerset (86%), and Staffordshire (83%).
Sioned Timothy, veterinary adviser for Merial Animal Health, said: “Gutworm can significantly reduce the productivity of the herd. Although adult dairy cows develop immunity to gutworm that makes them resilient to outward clinical signs of infection, it does not prevent them from becoming infected with Ostertagia ostertagi. This parasite burden can reduce milk yield by as much as 2.6 litres per cow per day1”
She continued: “Gutworm may also have a negative impact on fertility. Removing damaging gutworms from dairy cows may improve their fertility and has been linked to reduced calving to conception intervals and improved conception rates2 to levels comparable with animals without a gutworm burden.
"Calving is another key period in the production cycle. Optimising cow and heifer management during this period is critical to the animal’s health and productivity throughout the subsequent lactation. Cows treated for gutworms around the time of calving have been shown to increase their grazing time by almost an hour compared to untreated cows3. Improved appetite and higher dry matter intake helps cows to bridge the energy gap; maximising their production, and reducing the time it takes to get them back into calf4.”
The MOO test figures show that the UK dairy herd continues to be affected by high levels of gutworm challenge. At a time when maximising productivity is vital to dairy business success, farmers should seriously consider testing their herd this autumn and develop a treatment plan with their vet or animal health adviser based on the result.”
MOO tests will be available in autumn 2015. The results of MOO tests are sent to both the farmer and their vet or animal health advisor, to enable them to determine the best course of action and treatment.References1 Reist et al, Effect of eprinomectin treatment on milk yield and quality in dairy cows in South Tyrol, Italy. Veterinary Record 2011 168, 484-487 Vet Rec 2002151:377-3802 McPherson et al. Proceedings of the American Association of Veterinary Parasitologists. 44th Annual Meeting, New Orleans, Louisiana, USA, 1999 Abstr. 28.3 Forbes et al. Behavioural mechanisms underlying production responses in dairy cows treated with eprinomectin. 19th WAAVP Congress 2003, New Orleans4 Sanchez et al. The effect of eprinomectin treatment at calving on reproduction parameters in adult dairy cows in Canada. Preventative Veterinary Medicine 2002 56:165-177